problendoПроблемы ЭндокринологииProblems of Endocrinology0375-96602308-1430Endocrinology Research Centre10.14341/probl12874problendo-12874Research ArticleРепродуктивная эндокринологияReproductive EndocrinologyКлинические рекомендации "Синдром поликистозных яичников"Clinical guidelines «Polycystic Ovary Syndrome»https://orcid.org/0000-0002-3253-4512АдамянЛ. В.AdamyanL. V.

Адамян Лейла Владимировна, академик РАН, профессор, доктор медицинских наук

Москва

SPIN-код: 9836-2713

Leila V. Adamyan, MD, PhD, Professor

Москва

SPIN-код: 9836-2713

aleila@inbox.ruhttps://orcid.org/0000-0001-8425-0020АндрееваЕ. Н.AndreevaE. N.

Андреева Елена Николаевна, доктор медицинских наук

Москва

SPIN-код: 1239-2937

Elena N. Andreeva, MD, PhD, Dsc

Москва

SPIN-код: 1239-2937

endogin@mail.ruhttps://orcid.org/0000-0003-0696-5367АбсатароваЮ. С.AbsatarovaYu. S.

Абсатарова Юлия Сергеевна, кандидат медицинских наук

Москва

SPIN-код: 2220-9464

Yulia S. Absatarova, MD, PhD

Москва

SPIN-код: 2220-9464

korsil2008@yandex.ruhttps://orcid.org/0000-0003-4979-7420ГригорянО. Р.GrigoryanO. R.

Григорян Ольга Рафаэльевна, доктор медицинских наук

Москва

SPIN-код: 3060-8242

Оlga R. Grigoryan, MD, PhD, Dsc

Москва

SPIN-код: 3060-8242

iceberg1995@mail.ruhttps://orcid.org/0000-0002-8175-7886ДедовИ. И.DedovI. I.

Дедов Иван Иванович, доктор медицинских наук, профессор, академик РАН

Москва

SPIN-код: 5873-2280

Ivan I. Dedov, MD, PhD, Professor

Москва

SPIN-код: 5873-2280

dedov@endocrincentr.ruhttps://orcid.org/0000-0002-5634-7877МельниченкоГ. А.MelnichenkoG. A.

Мельниченко Галина Афанасьевна, академик РАН, профессор, доктор медицинских наук

Москва

SPIN-код: 8615-0038

Galina A. Melnichenko, MD, PhD, Professor

Москва

SPIN-код: 8615-0038

teofrast2000@mail.ruhttps://orcid.org/0000-0002-6271-7803СутуринаЛ. В.SuturinaL. V.

Сутурина Лариса Викторовна, доктор медицинских наук, профессор

Иркутск

SPIN-код: 9419-0244

Larisa V. Suturina, MD, PhD, Professor

Irkutsk

SPIN-код: 9419-0244

L_suturina@sbamsr.irk.ruФилипповО. С.FilippovO. S.

Филиппов Олег Семенович, доктор медицинских наук, профессор

Москва

eLibrary SPIN: 4404-4584

Oleg S. Filippov, MD, PhD, Professor

Moscow

eLibrary SPIN: 4404-4584

filippovolsem@yandex.ruhttps://orcid.org/0000-0001-7177-0254ШереметьеваЕ. В.SheremetyevaE. V.

Шереметьева Екатерина Викторовна, кандидат медицинских наук

117036, Москва, ул. Дмитрия Ульянова, д. 11

SPIN-код: 9413-5136

Ekaterina V. Sheremetyeva, MD, PhD

11 Dm. Ulyanov str., 117036, Moscow

SPIN-код: 9413-5136

s1981k@yandex.ruhttps://orcid.org/0000-0002-9065-5689ЧернухаГ. Е.ChernukhaG. E.

Чернуха Галина Евгеньевна, доктор медицинских наук, профессор

Москва

SPIN-код: 5514-3483

Galina E. Chernukha, MD, PhD, Dsc

Moscow

SPIN-код: 5514-3483

g_chernukha@oparina4.ruhttps://orcid.org/0000-0002-6551-4147ЯрмолинскаяМ. И.YarmolinskayaM. I.

Ярмолинская Мария Игоревна, доктор медицинских наук, профессор

Санкт-Петербург

SPIN-код: 3686-3605

Maria I. Yarmolinskaya, MD, PhD, Professor

Saint Petersburg

SPIN-код: 3686-3605

m.yarmolinskaya@gmail.comНациональный исследовательский центр акушерства, гинекологии и перинатологии им. В.И. Кулакова; Московский государственный медико-стоматологический университет им. А.И. ЕвдокимоваРоссияNational Medical Research Center of Obstetrics, Gynecology and Perinatology; Moscow State University of Medicine and Dentistry of A.I. EvdokimovRussian FederationНациональный медицинский исследовательский центр эндокринологии; Московский государственный медико-стоматологический университет им. А.И. ЕвдокимоваRussian FederationEndocrinology research centre; Moscow State University of Medicine and Dentistry of A.I. EvdokimovRussian FederationНациональный медицинский исследовательский центр эндокринологииRussian FederationEndocrinology research centreRussian FederationНаучный центр проблем здоровья семьи и репродукции человекаRussian FederationScientific Center for Family Health and Human Reproduction ProblemsRussian FederationПервый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский Университет); Министерство здравоохранения Российской ФедерацииRussian FederationI.M. Sechenov First Moscow State Medical University (Sechenov University); Ministry of Health of the Russian FederationRussian FederationНациональный исследовательский центр акушерства, гинекологии и перинатологии им. В.И. КулаковаRussian FederationNational Medical Research Center of Obstetrics, Gynecology and PerinatologyRussian FederationНаучно-исследовательский институт акушерства, гинекологии и репродукции им. Д.О. Отта; Северо-Западный государственный медицинский университет им. И.И. МечниковаRussian FederationResearch Institute of Obstetrics, Gynecology, and Reproductology named after D.O. Ott; North-Western State Medical University named after I.I. MechnikovRussian Federation202230042022682112127Copyright © Адамян Л.В., Андреева Е.Н., Абсатарова Ю.С., Григорян О.Р., Дедов И.И., Мельниченко Г.А., Сутурина Л.В., Филиппов О.С., Шереметьева Е.В., Чернуха Г.Е., Ярмолинская М.И., 20222022Адамян Л.В., Андреева Е.Н., Абсатарова Ю.С., Григорян О.Р., Дедов И.И., Мельниченко Г.А., Сутурина Л.В., Филиппов О.С., Шереметьева Е.В., Чернуха Г.Е., Ярмолинская М.И.Adamyan L.V., Andreeva E.N., Absatarova Y.S., Grigoryan O.R., Dedov I.I., Melnichenko G.A., Suturina L.V., Filippov O.S., Sheremetyeva E.V., Chernukha G.E., Yarmolinskaya M.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.probl-endojournals.ru/jour/article/view/12874

Синдром поликистозных яичников (СПЯ) — полигенное эндокринное расстройство, обусловленное как генетическими, так и эпигенетическими факторами. В зависимости от периода жизни женщины клиническая картина, диагностика, лечебная тактика заболевания различны. СПЯ имеет комплекс репродуктивных, метаболических и психологических особенностей. Целевая аудитория данных клинических рекомендаций — акушеры-гинекологи, эндокринологи, терапевты, врачи общей практики. В данных клинических рекомендациях все сведения ранжированы по уровням убедительности рекомендаций и достоверности доказательств в зависимости от количества и качества исследований по данной проблеме.

Polycystic ovary syndrome (PCOS) is a polygenic endocrine disorder caused by both genetic and epigenetic factors. Depending on the period of a woman’s life, the clinical picture, diagnosis, and treatment tactics of the disease are different. PCOS has a complex of reproductive, metabolic and psychological characteristics. The target audience of these clinical recommendations are obstetrician-gynecologists, endocrinologists, general practitioners, general practitioners. In these clinical guidelines, all information is ranked according to the level of persuasiveness of recommendations and the reliability of evidence, depending on the number and quality of studies on this issue.

синдром поликистозных яичниковановуляциясахарный диабет 2 типакомбинированные оральные контрацептивытестостеронбесплодиеpolycystic ovary syndromeanovulationtype 2 diabetes mellituscombined oral contraceptivestestosteroneinfertilityTeede Helena J. Misso Marie L. Costello Michael F. Dokras Anuja Laven Joop Moran Lisa Piltonen Terhi Norman Robert.J. Andersen Marianne Azziz Ricardo Balen Adam Baye Estifanos Boyle Jacqueline Brennan Leah Broekmans Frank Dabadghao Preeti Devoto Luigi Dewailly Didier Downes Linda Fauser Bart Franks Stephen Garad Rhonda M. Gibson-Helm Melanie Harrison Cheryce Hart Roger Hawkes Rachel Hirschberg Angelica Hoeger Kathleen Hohmann Femke Hutchison Samantha Joham Anju Johnson Louise Jordan Cailin Kulkarni Jayashri Legro Richard S. Li Rong Lujan Marla Malhotra Jaideep Mansfield Darren Marsh Kate McAllister Veryan Mocanu Edgar Mol Ben W. Ng Ernest Oberfield Sharon Ottey Sasha Peña Alexia Qiao Jie Redman Leanne Rodgers Raymond Rombauts Luk Romualdi Daniela Shah Duru Speight Jane Spritzer Poli Mara Stener-Victorin Elisabet Stepto Nigel Tapanainen Juha S. Tassone Eliza C. Thangaratinam Shakila Thondan Mala Tzeng Chii-Ruey van der Spuy Zephne Vanky Eszter Vogiatzi Maria Wan Angela Wijeyaratne Chandrika Witchel Selma Woolcock Jane Yildiz Bulent O. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome Fertility and Sterility 2018 07 364 379 110 3 10.1016/j.fertnstert.2018.05.004Goodman Neil F. Cobin Rhoda H. Futterweit Walter Glueck Jennifer S. Legro Richard S. Carmina Enrico American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Androgen Excess And Pcos Society Disease State Clinical Review: Guide To The Best Practices In The Evaluation And Treatment Of Polycystic Ovary Syndrome - Part 2 Endocrine Practice 2015 12 1415 1426 21 12 10.4158/ep15748.dscpt2Randeva HS, Tan BK, Weickert MO, et al. Cardiometabolic Aspects of the Polycystic Ovary Syndrome. Endocr Rev. 2012;33(5):812-841. doi: https://doi.org/10.1210/er.2012-1003Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Prim. 2016;2(1):16057. doi: https://doi.org/10.1038/nrdp.2016.57.Neven Adriana Laven Joop Teede Helena Boyle Jacqueline A Summary on Polycystic Ovary Syndrome: Diagnostic Criteria, Prevalence, Clinical Manifestations, and Management According to the Latest International Guidelines Seminars in Reproductive Medicine 2018 09 005 012 36 01 10.1055/s-0038-1668085Carmina Enrico Guastella Ettore Longo Rosa Advances in the Diagnosis and Treatment of PCOS Current Pharmaceutical Design 2016 07 5508 5514 22 36 10.2174/1381612822666160719105808 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Human Reproduction 2003 12 41 47 19 1 10.1093/humrep/deh098Spritzer Poli Barone Carolina Oliveira Fabiana Hirsutism in Polycystic Ovary Syndrome: Pathophysiology and Management Current Pharmaceutical Design 2016 07 5603 5613 22 36 10.2174/1381612822666160720151243Ezeh Uche Huang Andy Landay Melanie Azziz Ricardo Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome Journal of Women's Health 2018 06 892 902 27 7 10.1089/jwh.2017.6833Lizneva Daria Gavrilova-Jordan Larisa Walker Walidah Azziz Ricardo Androgen excess: Investigations and management Best Practice & Research Clinical Obstetrics & Gynaecology 2016 05 98 118 37 10.1016/j.bpobgyn.2016.05.003Escobar-Morreale H.F. Carmina E. Dewailly D. Gambineri A. Kelestimur F. Moghetti P. Pugeat M. Qiao J. Wijeyaratne C.N. Witchel S.F. Norman R.J. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society Human Reproduction Update 2011 11 146 170 18 2 10.1093/humupd/dmr042Legro Richard S. Schlaff William D. Diamond Michael P. Coutifaris Christos Casson Peter R. Brzyski Robert G. Christman Gregory M. Trussell J. C. Krawetz Stephen A. Snyder Peter J. Ohl Dana Carson Sandra A. Steinkampf Michael P. Carr Bruce R. McGovern Peter G. Cataldo Nicholas A. Gosman Gabriella G. Nestler John E. Myers Evan R. Santoro Nanette Eisenberg Esther Zhang Meizhuo Zhang Heping Total Testosterone Assays in Women with Polycystic Ovary Syndrome: Precision and Correlation with Hirsutism The Journal of Clinical Endocrinology & Metabolism 2010 09 5305 5313 95 12 10.1210/jc.2010-1123Lause Michael Kamboj Alisha Fernandez Faith Esteban Dermatologic manifestations of endocrine disorders Translational Pediatrics 2017 10 300 312 6 4 10.21037/tp.2017.09.08Melibary Yaser Taha Hidradenitis suppurativa in a patient with hyperandrogenism, insulin-resistance and acanthosis nigricans (HAIR-AN syndrome) Dermatology Reports 2018 07 10 1 10.4081/dr.2018.7546Keen MohammadAbid Shah IffatHassan Sheikh Gousia Cutaneous manifestations of polycystic ovary syndrome: A cross-sectional clinical study Indian Dermatology Online Journal 2017 03 104 8 2 10.4103/2229-5178.202275Rodgers Raymond J Avery Jodie C Moore Vivienne M Davies Michael J Azziz Ricardo Stener-Victorin Elisabet Moran Lisa J Robertson Sarah A Stepto Nigel K Norman Robert J Teede Helena J Complex diseases and co-morbidities: polycystic ovary syndrome and type 2 diabetes mellitus Endocrine Connections 2019 02 R71 R75 8 3 10.1530/ec-18-0502Legro Richard Obesity and PCOS: Implications for Diagnosis and Treatment Seminars in Reproductive Medicine 2012 10 496 506 30 06 10.1055/s-0032-1328878Glueck Charles J. Goldenberg Naila Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics Metabolism 2018 11 108 120 92 10.1016/j.metabol.2018.11.002Pasquali Renato Oriolo Claudia Obesity and Androgens in Women Frontiers of Hormone Research 2019 09 120 134 10.1159/000494908Zheng Sai-Hua Li Xue-Lian Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS Gynecological Endocrinology 2015 10 177 183 32 3 10.3109/09513590.2015.1111327Gibson-Helm Melanie Teede Helena Dunaif Andrea Dokras Anuja Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome The Journal of Clinical Endocrinology & Metabolism 2016 12 jc.2016 2963 10.1210/jc.2016-2963Dokras Anuja Saini Shailly Gibson-Helm Melanie Schulkin Jay Cooney Laura Teede Helena Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome Fertility and Sterility 2017 05 1380 1386.e1 107 6 10.1016/j.fertnstert.2017.04.011Balen Adam H. Morley Lara C. Misso Marie Franks Stephen Legro Richard S. Wijeyaratne Chandrika N. Stener-Victorin Elisabet Fauser Bart C.J.M. Norman Robert J. Teede Helena The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance Human Reproduction Update 2016 08 687 708 22 6 10.1093/humupd/dmw025Wild Robert A. Carmina Enrico Diamanti-Kandarakis Evanthia Dokras Anuja Escobar-Morreale Hector F. Futterweit Walter Lobo Rogerio Norman Robert J. Talbott Evelyn Dumesic Daniel A. Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society The Journal of Clinical Endocrinology & Metabolism 2010 04 2038 2049 95 5 10.1210/jc.2009-2724Andersen Marianne Glintborg Dorte Diagnosis and follow-up of type 2 diabetes in women with PCOS: a role for OGTT? European Journal of Endocrinology 2018 06 D1 D14 179 3 10.1530/eje-18-0237Anagnostis Panagiotis Tarlatzis Basil C. Kauffman Robert P. Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences Metabolism 2017 10 33 43 86 10.1016/j.metabol.2017.09.016Nolan Christopher J Prentki Marc Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift Diabetes and Vascular Disease Research 2019 02 118 127 16 2 10.1177/1479164119827611Pelanis Rasa Mellembakken Jan Roar Sundström-Poromaa Inger Ravn Pernille Morin-Papunen Laure Tapanainen Juha S Piltonen Terhi Puurunen Johanna Hirschberg Angelica Lindén Fedorcsak Peter Andersen Marianne Glintborg Dorte The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS Human Reproduction 2017 09 2279 2286 32 11 10.1093/humrep/dex294Condorelli Rosita A. Calogero Aldo E. Di Mauro Maurizio La Vignera Sandro PCOS and diabetes mellitus: from insulin resistance to altered beta pancreatic function, a link in evolution Gynecological Endocrinology 2017 06 665 667 33 9 10.1080/09513590.2017.1342240Jeanes Yvonne M. Reeves Sue Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges Nutrition Research Reviews 2017 02 97 105 30 1 10.1017/s0954422416000287Mohammad MB, Seghinsara AM. Polycystic ovary syndrome (PCOS), diagnostic criteria, and AMH. Asian Pacific J Cancer Prev. 2017;18(1):17-21. doi: https://doi.org/10.22034/APJCP.2017.18.1.17Teede Helena Misso Marie Tassone Eliza C. Dewailly Didier Ng Ernest Hy Azziz Ricardo Norman Robert J. Andersen Marianne Franks Stephen Hoeger Kathleen Hutchison Samantha Oberfield Sharon Shah Duru Hohmann Femke Ottey Sasha Dabadghao Preeti Laven Joop S.E. Anti-Müllerian Hormone in PCOS: A Review Informing International Guidelines Trends in Endocrinology & Metabolism 2019 05 467 478 30 7 10.1016/j.tem.2019.04.006Garg Deepika Tal Reshef The role of AMH in the pathophysiology of polycystic ovarian syndrome Reproductive BioMedicine Online 2016 04 15 28 33 1 10.1016/j.rbmo.2016.04.007Sova Henri Unkila-Kallio Leila Tiitinen Aila Hippeläinen Maritta Perheentupa Antti Tinkanen Helena Puukka Katri Bloigu Risto Piltonen Terhi Tapanainen Juha S. Morin-Papunen Laure Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes Gynecological Endocrinology 2019 01 595 600 35 7 10.1080/09513590.2018.1559807Yildiz B. O. Bozdag G. Yapici Z. Esinler I. Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria Human Reproduction 2012 07 3067 3073 27 10 10.1093/humrep/des232Alberti K.G.M.M. Eckel Robert H. Grundy Scott M. Zimmet Paul Z. Cleeman James I. Donato Karen A. Fruchart Jean-Charles James W. Philip T. Loria Catherine M. Smith Sidney C. Harmonizing the Metabolic Syndrome Circulation 2009 10 1640 1645 120 16 10.1161/circulationaha.109.192644Kakoly N S Khomami M B Joham A E Cooray S D Misso M L Norman R J Harrison C L Ranasinha S Teede H J Moran L J Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression Human Reproduction Update 2018 03 455 467 24 4 10.1093/humupd/dmy007Legro Richard S. Arslanian Silva A. Ehrmann David A. Hoeger Kathleen M. Murad M. Hassan Pasquali Renato Welt Corrine K. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline The Journal of Clinical Endocrinology & Metabolism 2013 10 4565 4592 98 12 10.1210/jc.2013-2350Rosenfield Robert L. The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum Journal of Pediatric and Adolescent Gynecology 2014 08 412 419 28 6 10.1016/j.jpag.2014.07.016Dewailly D. Lujan M. E. Carmina E. Cedars M. I. Laven J. Norman R. J. Escobar-Morreale H. F. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society Human Reproduction Update 2013 12 334 352 20 3 10.1093/humupd/dmt061Zhu Ruo-Yan Wong Yee-Chee Yong Eu-Leong Sonographic evaluation of polycystic ovaries Best Practice & Research Clinical Obstetrics & Gynaecology 2016 04 25 37 37 10.1016/j.bpobgyn.2016.02.005Federal'nye klinicheskie rekomendatsii. Bolezn' Itsenko-Kushinga. 2016.Federal'nye klinicheskie rekomendatsii. Vrozhdennaya disfunktsiya kory nadpochechnikov u vzroslykh. 2016.Federal'nye klinicheskie rekomendatsii. Giperprolaktinemiya. 2016.Alexander Erik K. Pearce Elizabeth N. Brent Gregory A. Brown Rosalind S. Chen Herbert Dosiou Chrysoula Grobman William A. Laurberg Peter Lazarus John H. Mandel Susan J. Peeters Robin P. Sullivan Scott 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum Thyroid 2017 01 315 389 27 3 10.1089/thy.2016.0457Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456-488. doi: https://doi.org/10.1016/j.fertnstert.2008.06.035Osibogun Olatokunbo Ogunmoroti Oluseye Michos Erin D. Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention Trends in Cardiovascular Medicine 2019 09 399 404 30 7 10.1016/j.tcm.2019.08.010Wild Robert A. Dyslipidemia in PCOS Steroids 2011 12 295 299 77 4 10.1016/j.steroids.2011.12.002Papadakis Georgios Kandaraki Eleni Papalou Olga Vryonidou Andromachi Diamanti‑Kandarakis Evanthia Is cardiovascular risk in women with PCOS a real risk? Current insights Minerva Endocrinology 2021 07 42 4 10.23736/s0391-1977.17.02609-8Meun Cindy Gunning Marlise N Louwers Yvonne V Peters Henrike Roos‐Hesselink Jolien Roeters van Lennep Jeanine Rueda Ochoa Oscar‐Leonel Appelman Yolande Lambalk Nils Boersma Eric Kavousi Maryam Fauser Bart CJM Laven Joop SE Baart Sara Benschop Laura Brouwers Laura Budde Ricardo Cannegieter Suzanne Dam Veerle Eijkemans Rene Ferrari Michel Franx Arie de Groot Christianne Hoek Annemieke Koffijberg Erik Koster Wendy Kruit Mark Lagerweij Giske Linstra Katie van der Lugt Aad Maas Angela Maassen van den Brink Antoinette Middeldorp Saskia Moons Karel GM van Rijn Bas Scheres Luuk van der Schouw Yvonne T. Steegers Eric Steegers Regine Terwindt Gisela Velthuis Birgitta Wermer Marieke Zick Bart Zoet Gerbrand The cardiovascular risk profile of middle‐aged women with polycystic ovary syndrome Clinical Endocrinology 2019 10 150 158 92 2 10.1111/cen.14117Delitala AP, Capobianco G, Delitala G, et al. Polycystic ovary syndrome, adipose tissue and metabolic syndrome. Arch Gynecol Obstet. 2017;296(3):405-419. doi: https://doi.org/10.1007/s00404-017-4429-2Damone Anna L. Joham Anju E. Loxton Deborah Earnest Arul Teede Helena J. Moran Lisa J. Depression, anxiety and perceived stress in women with and without PCOS: a community-based study Psychological Medicine 2018 08 1510 1520 49 09 10.1017/s0033291718002076Cooney Laura G. Dokras Anuja Depression and Anxiety in Polycystic Ovary Syndrome: Etiology and Treatment Current Psychiatry Reports 2017 09 19 11 10.1007/s11920-017-0834-2Rodriguez-Paris Daniel Remlinger-Molenda Agnieszka Kurzawa Rafał Głowińska Aleksandra Spaczyński Robert Rybakowski Filip Pawełczyk Leszek Banaszewska Beata The occurrence of psychiatric disorders in women with polycystic ovary syndrome Psychiatria Polska 2019 02 955 966 53 4 10.12740/pp/onlinefirst/93105Brutocao Claire Zaiem Feras Alsawas Mouaz Morrow Allison S. Murad M. Hassan Javed Asma Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis Endocrine 2018 07 318 325 62 2 10.1007/s12020-018-1692-3Lim Siew S Hutchison Samantha K Van Ryswyk Emer Norman Robert J Teede Helena J Moran Lisa J Lifestyle changes in women with polycystic ovary syndrome Cochrane Database of Systematic Reviews 2019 03 2019 3 10.1002/14651858.cd007506.pub4Oberg Emma Gidlöf Sebastian Jakson Ivika Mitsell Marja Tollet Egnell Petra Hirschberg Angelica Lindén Improved menstrual function in obese women with polycystic ovary syndrome after behavioural modification intervention-A randomized controlled trial Clinical Endocrinology 2018 12 468 478 90 3 10.1111/cen.13919dos Santos Isis Kelly Ashe Maureen C. Cobucci Ricardo Ney Soares Gustavo Mafaldo de Oliveira Maranhão Tecia Maria Dantas Paulo Moreira Silva The effect of exercise as an intervention for women with polycystic ovary syndrome Medicine 2020 04 e19644 99 16 10.1097/md.0000000000019644Teede Helena Tassone Eliza C. Piltonen Terhi Malhotra Jaideep Mol Ben W. Peña Alexia Witchel Selma F. Joham Anju McAllister Veryan Romualdi Daniela Thondan Mala Costello Michael Misso Marie L. Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta‐analyses Clinical Endocrinology 2019 05 479 489 91 4 10.1111/cen.14013Wang Qiu-Yi Song Yong Huang Wei Xiao Li Wang Qiu-Shi Feng Gui-Mei Comparison of Drospirenone- with Cyproterone Acetate-Containing Oral Contraceptives, Combined with Metformin and Lifestyle Modifications in Women with Polycystic Ovary Syndrome and Metabolic Disorders Chinese Medical Journal 2016 04 883 890 129 8 10.4103/0366-6999.179783Feng Wei Jia Yan-Yan Zhang Dong-Ya Shi Hui-Rong Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin Gynecological Endocrinology 2015 10 147 150 32 2 10.3109/09513590.2015.1101441Shah Aesha Dodson William C Kris-Etherton Penny M Kunselman Allen R Stetter Christy M Gnatuk Carol L Estes Stephanie J Allison Kelly C Sarwer David B Sluss Patrick M Coutifaris Christos Dokras Anuja Legro Richard S Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS The Journal of Clinical Endocrinology & Metabolism 2020 09 108 119 106 1 10.1210/clinem/dgaa682Amiri Mina Nahidi Fatemeh Yarandi Razieh Bidhendi Khalili Davood Tohidi Maryam Tehrani Fahimeh Ramezani Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial Health and Quality of Life Outcomes 2020 08 18 1 10.1186/s12955-020-01544-4Fonseka S, Wijeyaratne CN, Gawarammana IB, et al. Effectiveness of Low-dose Ethinylestradiol/Cyproterone Acetate and Ethinylestradiol/Desogestrel with and without Metformin on Hirsutism in Polycystic Ovary Syndrome: A Randomized, Double-blind, Triple-dummy Study. J Clin Aesthet Dermatol. 2020;13(7):18-23.World Health Organization. [Internet]. 2015 Quick Reference Chart for the WHO Medical Eligibility Criteria for Contraceptive Use. Adapted from Medical Eligibility Criteria for Contraceptive Use, 5th Edition 2015. Available from: https://www.fhi360.org/sites/default/files/media/documents/chart-medical-eligibility-contraceptives-english.pdf.Tay Chau T. Joham Anju E. Hiam Danielle S. Gadalla Moustafa A. Pundir Jyotsna Thangaratinam Shakila Teede Helena J. Moran Lisa J. Pharmacological and surgical treatment of nonreproductive outcomes in polycystic ovary syndrome: An overview of systematic reviews Clinical Endocrinology 2018 05 535 553 89 5 10.1111/cen.13753Bayram N. Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial BMJ 2004 01 192 0 328 7433 10.1136/bmj.328.7433.192Fraison Eloise Kostova Elena Moran Lisa J Bilal Sophia Ee Carolyn C Venetis Christos Costello Michael F Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome Cochrane Database of Systematic Reviews 2020 08 2020 8 10.1002/14651858.cd005552.pub3Jensterle Mojca Kravos Nika Aleksandra Ferjan Simona Goricar Katja Dolzan Vita Janez Andrej Long-term efficacy of metformin in overweight-obese PCOS: longitudinal follow-up of retrospective cohort Endocrine Connections 2020 01 44 54 9 1 10.1530/ec-19-0449Panda Soumya Ranjan Jain Madhu Jain Shuchi Saxena Riden Hota Smrutismita Effect of Orlistat Versus Metformin in Various Aspects of Polycystic Ovarian Syndrome: A Systematic Review of Randomized Control Trials The Journal of Obstetrics and Gynecology of India 2018 06 336 343 68 5 10.1007/s13224-018-1140-6Abdalla Mohammed Altigani Deshmukh Harshal Atkin Stephen Sathyapalan Thozhukat A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome Therapeutic Advances in Endocrinology and Metabolism 2020 07 204201882093830 11 10.1177/2042018820938305Showell Marian G Mackenzie-Proctor Rebecca Jordan Vanessa Hodgson Ruth Farquhar Cindy Inositol for subfertile women with polycystic ovary syndrome Cochrane Database of Systematic Reviews 2018 12 2018 12 10.1002/14651858.cd012378.pub2Wang Rui Li Wentao Bordewijk Esmée M Legro Richard S Zhang Heping Wu Xiaoke Gao Jingshu Morin-Papunen Laure Homburg Roy König Tamar E Moll Etelka Kar Sujata Huang Wei Johnson Neil P Amer Saad A Vegetti Walter Palomba Stefano Falbo Angela Özmen Ülkü Nazik Hakan Williams Christopher D Federica Grasso Lord Jonathan Sahin Yilmaz Bhattacharya Siladitya Norman Robert J van Wely Madelon Mol Ben Willem First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis Human Reproduction Update 2019 08 717 732 25 6 10.1093/humupd/dmz029Morley Lara C Tang Thomas Yasmin Ephia Norman Robert J Balen Adam H Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility Cochrane Database of Systematic Reviews 2017 11 2018 2 10.1002/14651858.cd003053.pub6Sharpe Abigail Morley Lara C Tang Thomas Norman Robert J Balen Adam H Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome Cochrane Database of Systematic Reviews 2019 12 10.1002/14651858.cd013505Wang Rui Kim Bobae V van Wely Madelon Johnson Neil P Costello Michael F Zhang Hanwang Ng Ernest Hung Yu Legro Richard S Bhattacharya Siladitya Norman Robert J Mol Ben Willem J Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis BMJ 2017 01 j138 10.1136/bmj.j138Weiss Nienke S Kostova Elena Nahuis Marleen Mol Ben Willem J van der Veen Fulco van Wely Madelon Gonadotrophins for ovulation induction in women with polycystic ovary syndrome Cochrane Database of Systematic Reviews 2019 01 10.1002/14651858.cd010290.pub3Bordewijk Esmée M Ng Ka Ying Bonnie Rakic Lidija Mol Ben Willem J Brown Julie Crawford Tineke J van Wely Madelon Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome Cochrane Database of Systematic Reviews 2020 02 10.1002/14651858.cd001122.pub5Lepine Sam Jo Junyoung Metwally Mostafa Cheong Ying C Ovarian surgery for symptom relief in women with polycystic ovary syndrome Cochrane Database of Systematic Reviews 2017 11 2017 11 10.1002/14651858.cd009526.pub2Christ Jacob P. Falcone Tommaso Bariatric Surgery Improves Hyperandrogenism, Menstrual Irregularities, and Metabolic Dysfunction Among Women with Polycystic Ovary Syndrome (PCOS) Obesity Surgery 2018 03 2171 2177 28 8 10.1007/s11695-018-3155-6Singh Devender Arumalla Kirit Aggarwal Sandeep Singla Vitish Ganie Ashraf Malhotra Neena Impact of Bariatric Surgery on Clinical, Biochemical, and Hormonal Parameters in Women with Polycystic Ovary Syndrome (PCOS) Obesity Surgery 2020 02 2294 2300 30 6 10.1007/s11695-020-04487-3 Consensus on infertility treatment related to polycystic ovary syndrome Human Reproduction 2008 02 462 477 23 3 10.1093/humrep/dem426Yaylalı Aslı Bakacak Murat Bakacak Zeyneb The efficacy of different insulin-sensitizing agents on treatment outcomes in patients with polycystic ovary syndrome who underwent in-vitro fertilization: A retrospective, record-based, comparative study Journal of Gynecology Obstetrics and Human Reproduction 2020 11 102006 50 1 10.1016/j.jogoh.2020.102006Bordewijk Esmée M Nahuis Marleen Costello Michael F Van der Veen Fulco Tso Leopoldo O Mol Ben Willem J van Wely Madelon Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome Cochrane Database of Systematic Reviews 2017 01 2017 1 10.1002/14651858.cd009090.pub2Tso Leopoldo O Costello Michael F Albuquerque Luiz Eduardo T Andriolo Regis B Macedo Cristiane R Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome Cochrane Database of Systematic Reviews 2020 12 2020 12 10.1002/14651858.cd006105.pub4Wu Yiqing Tu Mixue Huang Yun Liu Yifeng Zhang Dan Association of Metformin With Pregnancy Outcomes in Women With Polycystic Ovarian Syndrome Undergoing In Vitro Fertilization JAMA Network Open 2020 08 e2011995 3 8 10.1001/jamanetworkopen.2020.11995Bahri Khomami Mahnaz Joham Anju E. Boyle Jacqueline A. Piltonen Terhi Arora Chavy Silagy Michael Misso Marie L. Teede Helena J. Moran Lisa J. The role of maternal obesity in infant outcomes in polycystic ovary syndrome—A systematic review, meta‐analysis, and meta‐regression Obesity Reviews 2019 02 842 858 20 6 10.1111/obr.12832Bahri Khomami Mahnaz Joham Anju E. Boyle Jacqueline A. Piltonen Terhi Silagy Michael Arora Chavy Misso Marie L. Teede Helena J. Moran Lisa J. Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity—A systematic review, meta‐analysis, and meta‐regression Obesity Reviews 2019 01 659 674 20 5 10.1111/obr.12829Gunning Marlise N Sir Petermann Teresa Crisosto Nicolas van Rijn Bas B de Wilde Marlieke A Christ Jacob P Uiterwaal C S P M de Jager Wilco Eijkemans Marinus J C Kunselman Allen R Legro Richard S Fauser Bart C J M Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis Human Reproduction Update 2019 12 104 118 26 1 10.1093/humupd/dmz036Rodgers Raymond J Avery Jodie C Moore Vivienne M Davies Michael J Azziz Ricardo Stener-Victorin Elisabet Moran Lisa J Robertson Sarah A Stepto Nigel K Norman Robert J Teede Helena J Complex diseases and co-morbidities: polycystic ovary syndrome and type 2 diabetes mellitus Endocrine Connections 2019 02 R71 R75 8 3 10.1530/ec-18-0502Horowitz Eran Weissman Ariel The stair-step approach in treatment of anovulatory PCOS patients Therapeutic Advances in Reproductive Health 2020 05 263349412090881 14 10.1177/2633494120908818Gadalla MA, Norman RJ, Tay CT, et al. Medical and surgical treatment of reproductive outcomes in polycystic ovary syndrome: An overview of systematic reviews. Int J Fertil Steril. 2020;13(4):257-270. doi: https://doi.org/10.22074/ijfs.2020.5608Obeid Rima Schön Christiane Wilhelm Manfred Pietrzik Klaus Pilz Stefan Dietary and lifestyle predictors of folate insufficiency in non-supplemented German women International Journal of Food Sciences and Nutrition 2018 09 367 376 70 3 10.1080/09637486.2018.1511686Daly Leslie E. Folate Levels and Neural Tube Defects JAMA 2011 12 1698 274 21 10.1001/jama.1995.03530210052030Moreno Luis A. Gottrand Frédéric Huybrechts Inge Ruiz Jonatan R. González-Gross Marcela DeHenauw Stefaan Nutrition and Lifestyle in European Adolescents: The HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) Study Advances in Nutrition 2014 09 615S 623S 5 5 10.3945/an.113.005678Osterhues Anja Holzgreve Wolfgang Michels Karin B Shall we put the world on folate? The Lancet 2009 09 959 961 374 9694 10.1016/s0140-6736(09)61646-9Escobar-Morreale HF, Luque-Ramírez M, González F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011;95(3):1048-1058.e2. doi: https://doi.org/10.1016/j.fertnstert.2010.11.036Carvalho Maria João Subtil Simone Rodrigues Ângela Oliveira Joana Figueiredo-Dias Margarida Controversial association between polycystic ovary syndrome and breast cancer European Journal of Obstetrics & Gynecology and Reproductive Biology 2019 10 125 132 243 10.1016/j.ejogrb.2019.10.011Meczekalski Blazej Pérez-Roncero Gonzalo R. López-Baena María T. Chedraui Peter Pérez-López Faustino R. The polycystic ovary syndrome and gynecological cancer risk Gynecological Endocrinology 2020 02 289 293 36 4 10.1080/09513590.2020.1730794Wen Yaokai Wu Xiangrong Peng Haoxin Li Caichen Jiang Yu Su Zixuan Liang Hengrui Liu Jun He Jianxing Liang Wenhua Breast cancer risk in patients with polycystic ovary syndrome: a Mendelian randomization analysis Breast Cancer Research and Treatment 2020 10 799 806 185 3 10.1007/s10549-020-05973-zBelenkaya L.V. Criteria of obesity for Asian population. Literature review Acta Biomedica Scientifica 2018 06 99 102 3 3 10.29413/abs.2018-3.3.15Peña Alexia S. Witchel Selma F. Hoeger Kathleen M. Oberfield Sharon E. Vogiatzi Maria G. Misso Marie Garad Rhonda Dabadghao Preeti Teede Helena Adolescent polycystic ovary syndrome according to the international evidence-based guideline BMC Medicine 2020 03 18 1 10.1186/s12916-020-01516-xAversa Antonio La Vignera Sandro Rago Rocco Gambineri Alessandra Nappi Rossella E. Calogero Aldo E. Ferlin Alberto Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions Frontiers in Endocrinology 2020 08 11 10.3389/fendo.2020.00516Kazerooni Talieh Asadi Nasrin Dehbashi Sedigheh Zolghadri Jaleh Effect of folic acid in women with and without insulin resistance who have hyperhomocysteinemic polycystic ovary syndrome International Journal of Gynecology & Obstetrics 2008 03 156 160 101 2 10.1016/j.ijgo.2007.10.024Mondal Kalyani Chakraborty Pratip Kabir Syed N. Hyperhomocysteinemia and hyperandrogenemia share PCSK9-LDLR pathway to disrupt lipid homeostasis in PCOS Biochemical and Biophysical Research Communications 2018 06 8 13 503 1 10.1016/j.bbrc.2018.04.078Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270-284. doi: https://doi.org/10.1038/nrendo.2018.24Glintborg Dorte Rubin Katrine Hass Nybo Mads Abrahamsen Bo Andersen Marianne Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome Cardiovascular Diabetology 2018 03 17 1 10.1186/s12933-018-0680-5Farquhar Cindy Brown Julie Marjoribanks Jane Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome Cochrane Database of Systematic Reviews 2012 06 10.1002/14651858.cd001122.pub4Lim S. S. Norman R. J. Davies M. J. Moran L. J. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis Obesity Reviews 2012 11 95 109 14 2 10.1111/j.1467-789x.2012.01053.xWild Sarah Pierpoint Tracey Jacobs Howard McKeigue Paul Long-term consequences of polycystic ovary syndrome: Results of a 31 year follow-up study Human Fertility 2007 06 101 105 3 2 10.1080/1464727002000198781van Zuuren EJ, Fedorowicz Z, Carter B, Pandis N. Interventions for hirsutism (excluding laser and photoepilation therapy alone). Cochrane Database Syst Rev. 2015;4. doi: https://doi.org/10.1002/14651858.CD010334.pub2Abu Hashim Hatem Foda Osama El Rakhawy Mohamed Unilateral or bilateral laparoscopic ovarian drilling in polycystic ovary syndrome: a meta-analysis of randomized trials Archives of Gynecology and Obstetrics 2018 01 859 870 297 4 10.1007/s00404-018-4680-1Mulder CL Lassi ZS Grieger JA Ali A Jankovic‐Karasoulos T Roberts CT Andraweera PH Cardio‐metabolic risk factors among young infertile women: a systematic review and meta‐analysis BJOG: An International Journal of Obstetrics & Gynaecology 2020 02 930 939 127 8 10.1111/1471-0528.16171Kahal Hassan Kyrou Ioannis Uthman Olalekan A. Brown Anna Johnson Samantha Wall Peter D. H. Metcalfe Andrew Parr David G. Tahrani Abd A. Randeva Harpal S. The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis Sleep and Breathing 2019 05 339 350 24 1 10.1007/s11325-019-01835-1Oriolo C. Fanelli F. Castelli S. Mezzullo M. Altieri P. Corzani F. Pelusi C. Repaci A. Di Dalmazi G. Vicennati V. Baldazzi L. Menabò S. Dormi A. Nardi E. Brillanti G. Pasquali R. Pagotto U. Gambineri A. Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone Journal of Endocrinological Investigation 2020 03 1499 1509 43 10 10.1007/s40618-020-01235-3Jonard Sophie Robert Yann Dewailly Didier Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries Human Reproduction 2005 07 2893 2898 20 10 10.1093/humrep/dei159Pinola P. Morin-Papunen L. C. Bloigu A. Puukka K. Ruokonen A. Jarvelin M.- R. Franks S. Tapanainen J. S. Lashen H. Anti-Mullerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study Human Reproduction 2014 07 2317 2325 29 10 10.1093/humrep/deu182Moran Lisa J. Misso Marie L. Wild Robert A. Norman Robert J. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis Human Reproduction Update 2010 02 347 363 16 4 10.1093/humupd/dmq001Tosi Flavia Fiers Tom Kaufman Jean-Marc Dall'Alda Marlene Moretta Rossella Giagulli Vito Angelo Bonora Enzo Moghetti Paolo Implications of Androgen Assay Accuracy in the Phenotyping of Women With Polycystic Ovary Syndrome The Journal of Clinical Endocrinology & Metabolism 2015 12 610 618 101 2 10.1210/jc.2015-2807Steck T. Wernze H. Ist die Bestimmung des «freien Androgenindexes» zum Hormonscreening bei polyzystischen Ovarien sinnvoll? Gynäkologisch-geburtshilfliche Rundschau 2009 12 173 179 33 3 10.1159/000272100Kollmann M. Martins W. P. Lima M. L. S. Craciunas L. Nastri C. O. Richardson A. Raine-Fenning N. Strategies for improving outcome of assisted reproduction in women with polycystic ovary syndrome: systematic review and meta-analysis Ultrasound in Obstetrics & Gynecology 2016 02 709 718 48 6 10.1002/uog.15898Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973.e33. doi: https://doi.org/10.1016/j.jaad.2015.12.037Barrionuevo Patricia Nabhan Mohammed Altayar Osama Wang Zhen Erwin Patricia J Asi Noor Martin Kathryn A Murad M Hassan Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis The Journal of Clinical Endocrinology & Metabolism 2018 03 1258 1264 103 4 10.1210/jc.2017-02052Derewianka-Polak Magdalena Polak Grzegorz Tkaczuk-Włach Joanna Gerhant Aneta Olajossy Marcin Polycystic ovary syndrome and mental disorders – discussion on the recommendations of the European Society of Human Reproduction and Embryology (ESHRE) Current Problems of Psychiatry 2020 03 269 272 20 4 10.2478/cpp-2019-0018Zeinalzadeh M., Basirat Z., Esmailpour M. Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. The Journal of reproductive medicine. 2010;55(1-2):36-40.

The authors declare that there are no conflicts of interest present.